Blockade of LIF and PD-L1 Enhances Chemotherapy in Preclinical PDAC Models is a research paper published in Cancers (2025). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
AstraZeneca
Grant: R01CA230277
AstraZeneca
Grant: R01CA236390
AstraZeneca
Grant: R01CA262580
AstraZeneca
Grant: R01CA168863
NIH HHS
Grant: 1R01CA230277-23A4
NIH HHS
Grant: 1R01CA262580-24A3
NIH HHS
Grant: 1R01CA236390-23A5
NIAID NIH HHS
Grant: T32 AI007285
NIH HHS
Grant: 1R01CA168863-22A9
National Institutes of Health
Grant: 5R01CA262580-02
Repolarizing the Tumor and Metastatic Microenvironments to Treat Patients with Pancreatic Cancer
National Institutes of Health
Grant: 5R01CA236390-03
Targeting adrenergic stress pathways to Increase tumor sensitivity to radiation and promote development of an anti-tumor immune response
National Institutes of Health
Grant: 5R01CA230277-03
Development of a New Strategy to Treat Locally Advanced Pancreatic Cancer
National Institutes of Health
Grant: 1R01CA168863-01A1
CCR2 BLOCKADE IN HUMAN PANCREATIC CANCER
Fields of Study
Keywords